- $4.82bn
- $4.66bn
- $536.77m
- 99
- 12
- 88
- 73
Annual cashflow statement for Exponent, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2020 January 3rd | 2021 December 31st | 2021 January 1st | 2022 December 30th | 2023 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 82.5 | 101 | 82.6 | 102 | 100 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 19.2 | 21.2 | 19 | 23.4 | 23.6 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.46 | 1.67 | -1.44 | -31.7 | -5.57 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 108 | 125 | 103 | 93.8 | 127 |
| Capital Expenditures | -23 | -6.83 | -4.99 | -12 | -16.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 27.3 | 45 | 10 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 4.27 | 38.2 | 5.02 | -12 | -16.4 |
| Financing Cash Flow Items | -11.2 | -15.7 | -15.3 | -12.9 | -9.94 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -63.4 | -62.8 | -88.4 | -216 | -86 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 49.4 | 100 | 21.1 | -136 | 25.7 |